$VXRT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Vaxart, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Vaxart, Inc.. Get notifications about new insider transactions in Vaxart, Inc. for free.

Page: < prev 1 2 3 4 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 05 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Grant	A	0.00	24,000	0	53,650	29.7 K to 53.7 K (+80.94 %)
Apr 05 2010	NABI	Aviragen Therapeut ...	FAHIM RAAFAT E F	President, CEO and ...	Option Exercise	A	5.49	125,000	686,250	125,000
Apr 05 2010	NABI	Aviragen Therapeut ...	FAHIM RAAFAT E F	President, CEO and ...	Grant	A	0.00	50,000	0	333,819	283.8 K to 333.8 K (+17.62 %)
Apr 05 2010	NABI	Aviragen Therapeut ...	FAHIM RAAFAT E F	President, CEO and ...	Buy	J	2.41	5,404	12,999	283,819	278.4 K to 283.8 K (+1.94 %)
Apr 05 2010	NABI	Aviragen Therapeut ...	FAHIM RAAFAT E F	President, CEO and ...	Buy	J	2.41	5,404	12,999	278,415	273 K to 278.4 K (+1.98 %)
Apr 05 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Option Exercise	A	5.49	90,000	494,100	90,000
Apr 05 2010	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Grant	A	0.00	36,000	0	118,500	82.5 K to 118.5 K (+43.64 %)
Mar 26 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	6.24	234	1,460	251,883	252.1 K to 251.9 K (-0.09 %)
Mar 26 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	6.25	64,793	404,833	252,117	316.9 K to 252.1 K (-20.45 %)
Mar 24 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	6.24	28,510	177,902	316,910	345.4 K to 316.9 K (-8.25 %)
Mar 23 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.99	7,800	46,722	345,420	353.2 K to 345.4 K (-2.21 %)
Mar 22 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.97	200	1,194	352,620	352.8 K to 352.6 K (-0.06 %)
Mar 22 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.96	6,381	38,031	352,820	359.2 K to 352.8 K (-1.78 %)
Mar 17 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Sell	S	5.93	9,873	58,547	29,650	39.5 K to 29.7 K (-24.98 %)
Mar 19 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.96	2,619	15,609	359,201	361.8 K to 359.2 K (-0.72 %)
Mar 19 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.94	8,800	52,272	361,820	370.6 K to 361.8 K (-2.37 %)
Mar 17 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Option Exercise	M	3.95	1,125	4,444	14,625
Mar 17 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Sell	S	5.95	1,125	6,694	39,523	40.6 K to 39.5 K (-2.77 %)
Mar 17 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Buy	M	3.95	1,125	4,444	40,648	39.5 K to 40.6 K (+2.85 %)
Mar 17 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.93	200	1,186	370,620	370.8 K to 370.6 K (-0.05 %)
Mar 16 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.93	16,000	94,816	370,820	386.8 K to 370.8 K (-4.14 %)
Mar 16 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.93	600	3,558	386,820	387.4 K to 386.8 K (-0.15 %)
Mar 15 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.88	180,700	1,062,335	387,420	568.1 K to 387.4 K (-31.81 %)
Mar 12 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.74	16,100	92,414	568,120	584.2 K to 568.1 K (-2.76 %)
Mar 10 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.75	3,200	18,393	584,220	587.4 K to 584.2 K (-0.54 %)
Mar 04 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Option Exercise	M	3.95	2,250	8,888	15,750
Mar 04 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Sell	S	5.45	2,250	12,263	39,523	41.8 K to 39.5 K (-5.39 %)
Mar 04 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Buy	M	3.95	2,250	8,888	41,773	39.5 K to 41.8 K (+5.69 %)
Mar 04 2010	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Buy	J	2.41	5,404	12,999	39,523	34.1 K to 39.5 K (+15.84 %)
Jan 15 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.49	13,800	75,774	587,420	601.2 K to 587.4 K (-2.30 %)
Jan 14 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.49	86,200	473,367	601,220	687.4 K to 601.2 K (-12.54 %)
Jan 08 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.29	46,157	244,171	687,420	733.6 K to 687.4 K (-6.29 %)
Jan 08 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.29	3,443	18,213	733,577	737 K to 733.6 K (-0.47 %)
Jan 08 2010	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.24	42,365	222,154	737,020	779.4 K to 737 K (-5.44 %)
Dec 23 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.24	8,035	42,103	779,385	787.4 K to 779.4 K (-1.02 %)
Dec 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.24	4,045	21,196	787,420	791.5 K to 787.4 K (-0.51 %)
Nov 25 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	5.00	602	3,011	82,500	83.1 K to 82.5 K (-0.72 %)
Nov 25 2009	NABI	Aviragen Therapeut ...	DAVIS PETER B	Director	Buy	P	4.98	2,200	10,956	10,814	8.6 K to 10.8 K (+25.54 %)
Nov 25 2009	NABI	Aviragen Therapeut ...	DAVIS PETER B	Director	Buy	P	4.98	800	3,983	8,614	7.8 K to 8.6 K (+10.24 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.89	5,502	26,905	83,102	88.6 K to 83.1 K (-6.21 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.90	7,136	34,966	88,604	95.7 K to 88.6 K (-7.45 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.91	2,000	9,820	95,740	97.7 K to 95.7 K (-2.05 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.92	1,000	4,920	97,740	98.7 K to 97.7 K (-1.01 %)
Nov 23 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	4.90	2,500	12,250	98,740	101.2 K to 98.7 K (-2.47 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.64	196	909	791,465	791.7 K to 791.5 K (-0.02 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.74	4,804	22,771	791,661	796.5 K to 791.7 K (-0.60 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.75	5,000	23,750	796,465	801.5 K to 796.5 K (-0.62 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.76	500	2,380	801,465	802 K to 801.5 K (-0.06 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.89	500	2,445	801,965	802.5 K to 802 K (-0.06 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.94	1,000	4,940	802,465	803.5 K to 802.5 K (-0.12 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.95	1,000	4,950	803,465	804.5 K to 803.5 K (-0.12 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.99	43,163	215,383	804,465	847.6 K to 804.5 K (-5.09 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.00	33,803	169,015	847,628	881.4 K to 847.6 K (-3.84 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.01	10,335	51,778	881,431	891.8 K to 881.4 K (-1.16 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.02	2,100	10,542	891,766	893.9 K to 891.8 K (-0.23 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.03	10,058	50,592	893,866	903.9 K to 893.9 K (-1.11 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.04	1,909	9,621	903,924	905.8 K to 903.9 K (-0.21 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.05	6,232	31,472	905,833	912.1 K to 905.8 K (-0.68 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.06	100	506	912,065	912.2 K to 912.1 K (-0.01 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.08	300	1,524	912,165	912.5 K to 912.2 K (-0.03 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.10	5,000	25,500	912,465	917.5 K to 912.5 K (-0.54 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.12	500	2,560	917,465	918 K to 917.5 K (-0.05 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.22	500	2,610	917,965	918.5 K to 918 K (-0.05 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.24	58,709	307,635	918,465	977.2 K to 918.5 K (-6.01 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	5.25	200	1,050	977,174	977.4 K to 977.2 K (-0.02 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	LYNCH TIMOTHY P	Director	Sell	S	5.20	3,846	19,999	0	3.8 K to 0 (-100.00 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Sell	S	4.97	4,900	24,353	31,119	36 K to 31.1 K (-13.60 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Sell	S	4.97	2,000	9,942	36,019	38 K to 36 K (-5.26 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Sell	S	4.47	7,674	34,336	38,019	45.7 K to 38 K (-16.79 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.49	70,147	314,960	977,374	1 M to 977.4 K (-6.70 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.50	102,912	463,104	1,047,521	1.2 M to 1 M (-8.95 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.51	38,319	172,819	1,150,433	1.2 M to 1.2 M (-3.22 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.52	9,175	41,471	1,188,752	1.2 M to 1.2 M (-0.77 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.53	4,339	19,656	1,197,927	1.2 M to 1.2 M (-0.36 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.54	400	1,816	1,202,266	1.2 M to 1.2 M (-0.03 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.55	1,200	5,460	1,202,666	1.2 M to 1.2 M (-0.10 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.56	2,700	12,312	1,203,866	1.2 M to 1.2 M (-0.22 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.57	1,700	7,769	1,206,566	1.2 M to 1.2 M (-0.14 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.58	11,525	52,785	1,208,266	1.2 M to 1.2 M (-0.94 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.59	2,500	11,475	1,219,791	1.2 M to 1.2 M (-0.20 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.60	3,375	15,525	1,222,291	1.2 M to 1.2 M (-0.28 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.61	2,500	11,525	1,225,666	1.2 M to 1.2 M (-0.20 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.62	1,300	6,006	1,228,166	1.2 M to 1.2 M (-0.11 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.63	300	1,389	1,229,466	1.2 M to 1.2 M (-0.02 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Sell	S	4.59	2,884	13,238	1,229,766	1.2 M to 1.2 M (-0.23 %)
Nov 18 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Buy	W	0.00	17,000	0	1,232,650	1.2 M to 1.2 M (+1.40 %)
Jul 01 2009	NABI	Aviragen Therapeut ...	KNOTT DAVID M	10% Owner	Sell	S	2.45	200	490	69,900	70.1 K to 69.9 K (-0.29 %)
Jul 01 2009	NABI	Aviragen Therapeut ...	KNOTT DAVID M	10% Owner	Sell	S	2.45	44,200	108,290	1,739,953	1.8 M to 1.7 M (-2.48 %)
Jul 01 2009	NABI	Aviragen Therapeut ...	KNOTT DAVID M	10% Owner	Sell	S	2.45	45,600	111,720	1,094,400	1.1 M to 1.1 M (-4.00 %)
Jul 01 2009	NABI	Aviragen Therapeut ...	KNOTT DAVID M	10% Owner	Sell	S	2.52	300	756	70,100	70.4 K to 70.1 K (-0.43 %)
Jul 01 2009	NABI	Aviragen Therapeut ...	KNOTT DAVID M	10% Owner	Sell	S	2.52	53,800	135,576	1,784,153	1.8 M to 1.8 M (-2.93 %)
Jul 01 2009	NABI	Aviragen Therapeut ...	KNOTT DAVID M	10% Owner	Sell	S	2.52	55,500	139,860	1,140,000	1.2 M to 1.1 M (-4.64 %)
May 27 2009	NABI	Aviragen Therapeut ...	SUDOVAR STEPHEN	Director	Option Exercise	A	2.66	20,000	53,200	20,000
May 27 2009	NABI	Aviragen Therapeut ...	JENCKES LINDA	Director	Option Exercise	A	2.66	20,000	53,200	20,000
May 27 2009	NABI	Aviragen Therapeut ...	LYNCH TIMOTHY P	Director	Option Exercise	A	2.66	20,000	53,200	20,000
May 27 2009	NABI	Aviragen Therapeut ...	LYNCH TIMOTHY P	Director	Option Exercise	A	2.66	20,000	53,200	20,000
May 27 2009	NABI	Aviragen Therapeut ...	DAVIS PETER B	Director	Option Exercise	A	2.66	20,000	53,200	20,000
May 27 2009	NABI	Aviragen Therapeut ...	CASTALDI DAVID L	Director	Option Exercise	A	2.66	20,000	53,200	20,000
May 27 2009	NABI	Aviragen Therapeut ...	HARVEY RICHARD A JR	Director	Option Exercise	A	2.66	20,000	53,200	20,000
May 27 2009	NABI	Aviragen Therapeut ...	COX GEOFFREY F	Director	Option Exercise	A	2.66	40,000	106,400	40,000
May 27 2009	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Option Exercise	A	2.66	20,000	53,200	20,000
Apr 03 2009	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Option Exercise	A	3.78	45,000	170,100	45,000
Apr 03 2009	NABI	Aviragen Therapeut ...	Kalnik Matthew W.	SVP Strategic Plan. ...	Grant	A	0.00	18,000	0	45,693	27.7 K to 45.7 K (+65.00 %)
Apr 03 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Option Exercise	A	3.78	90,000	340,200	90,000
Apr 03 2009	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Grant	A	0.00	30,000	0	101,240	71.2 K to 101.2 K (+42.11 %)
Apr 03 2009	NABI	Aviragen Therapeut ...	FAHIM RAAFAT E F	President, CEO and ...	Option Exercise	A	3.78	115,000	434,700	115,000
Apr 03 2009	NABI	Aviragen Therapeut ...	FAHIM RAAFAT E F	President, CEO and ...	Grant	A	0.00	45,000	0	270,064	225.1 K to 270.1 K (+19.99 %)
Jan 14 2009	NABI	Aviragen Therapeut ...	KNOTT DAVID M	10% Owner	Buy	P	3.84	58,500	224,640	139,800	81.3 K to 139.8 K (+71.96 %)
Jun 09 2008	NABI	Aviragen Therapeut ...	HARVEY RICHARD A JR	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Jun 12 2008	NABI	Aviragen Therapeut ...	SUDOVAR STEPHEN	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Jun 10 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Jun 09 2008	NABI	Aviragen Therapeut ...	LYNCH TIMOTHY P	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Jun 09 2008	NABI	Aviragen Therapeut ...	JENCKES LINDA	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Jun 09 2008	NABI	Aviragen Therapeut ...	DAVIS PETER B	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Jun 09 2008	NABI	Aviragen Therapeut ...	COX GEOFFREY F	Non-Executive Chair ...	Option Exercise	A	3.84	40,000	153,600	40,000
Jun 09 2008	NABI	Aviragen Therapeut ...	Aryeh Jason	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Jun 09 2008	NABI	Aviragen Therapeut ...	CASTALDI DAVID L	Director	Option Exercise	A	3.84	20,000	76,800	20,000
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.11	1,000	4,110	55,759	56.8 K to 55.8 K (-1.76 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.10	849	3,481	56,759	57.6 K to 56.8 K (-1.47 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.10	100	410	57,608	57.7 K to 57.6 K (-0.17 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.09	11,632	47,575	57,708	69.3 K to 57.7 K (-16.78 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.08	2,101	8,572	69,340	71.4 K to 69.3 K (-2.94 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.07	1,000	4,070	71,441	72.4 K to 71.4 K (-1.38 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.06	2,950	11,977	72,441	75.4 K to 72.4 K (-3.91 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.06	300	1,217	75,391	75.7 K to 75.4 K (-0.40 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.05	1,707	6,913	75,691	77.4 K to 75.7 K (-2.21 %)
Apr 07 2008	NABI	Aviragen Therapeut ...	Hudson Leslie	Director	Sell	S	4.04	2,361	9,538	77,398	79.8 K to 77.4 K (-2.96 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.50	897	3,140	18,157	19.1 K to 18.2 K (-4.71 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.35	100	335	19,054	19.2 K to 19.1 K (-0.52 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.34	100	334	19,154	19.3 K to 19.2 K (-0.52 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.33	1,100	3,663	19,254	20.4 K to 19.3 K (-5.40 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.33	100	333	20,354	20.5 K to 20.4 K (-0.49 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.31	100	331	20,454	20.6 K to 20.5 K (-0.49 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.30	4,800	15,840	20,554	25.4 K to 20.6 K (-18.93 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.30	100	330	25,354	25.5 K to 25.4 K (-0.39 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.30	200	659	25,454	25.7 K to 25.5 K (-0.78 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.29	800	2,632	25,654	26.5 K to 25.7 K (-3.02 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.28	1,000	3,280	26,454	27.5 K to 26.5 K (-3.64 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.28	100	328	27,454	27.6 K to 27.5 K (-0.36 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.27	5,095	16,661	27,554	32.6 K to 27.6 K (-15.61 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.27	100	327	32,649	32.7 K to 32.6 K (-0.31 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.26	19,012	61,979	32,749	51.8 K to 32.7 K (-36.73 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.26	200	652	51,761	52 K to 51.8 K (-0.38 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.26	100	326	51,961	52.1 K to 52 K (-0.19 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.26	700	2,279	52,061	52.8 K to 52.1 K (-1.33 %)
Mar 12 2008	NABI	Aviragen Therapeut ...	Siegel Jordan I	Sr. VP Fin. & Admin ...	Sell	S	3.25	32,896	106,912	52,761	85.7 K to 52.8 K (-38.40 %)
Mar 07 2008	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	3.74	600	2,244	41,240	41.8 K to 41.2 K (-1.43 %)
Mar 07 2008	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	3.74	754	2,820	41,840	42.6 K to 41.8 K (-1.77 %)
Mar 07 2008	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	3.73	1,136	4,237	42,594	43.7 K to 42.6 K (-2.60 %)
Mar 07 2008	NABI	Aviragen Therapeut ...	Kessler Paul D.	SVP Clinical, Med. ...	Sell	S	3.74	600	2,246	43,730	44.3 K to 43.7 K (-1.35 %)

Page: < prev 1 2 3 4 5 next >